From the Guidelines
Aspiration pneumonia is most commonly caused by Gram-negative pathogens and S. aureus, rather than anaerobes, and should be treated with antibiotics directed towards these upper airway colonizers. According to the IDSA/ATS 2019 guidelines, as stated in the study by 1, the majority of aspiration pneumonias are caused by Gram-negative pathogens, and antibiotics should be directed towards these organisms, rather than anaerobes, unless lung abscess or empyema is suspected.
The primary organisms responsible for aspiration pneumonia include:
- Gram-negative pathogens such as Pseudomonas aeruginosa and Enterobacteriaceae
- S. aureus, including methicillin-resistant forms (MRSA)
- Other potential pathogens, such as Haemophilus influenzae and Streptococcus pneumoniae, may also be involved, but to a lesser extent.
Treatment of aspiration pneumonia typically involves broad-spectrum antibiotics, such as:
- Piperacillin-tazobactam (4.5g IV every 6-8 hours)
- A combination of clindamycin (600mg IV every 8 hours) plus a respiratory fluoroquinolone
- The duration of treatment is usually 7-14 days, depending on the clinical response, as stated in the study by 1.
It's worth noting that the polymicrobial nature of aspiration pneumonia is influenced by the patient's oral hygiene, dental status, and whether the aspiration occurred in a community or healthcare setting, as mentioned in the study by 1. Patients with poor dentition, alcoholism, or those who are hospitalized tend to have more virulent organisms colonizing their oropharynx, leading to more severe infections when aspiration occurs.
From the Research
Aspiration Pneumonia Causing Organisms
- The causative organisms of aspiration pneumonia have evolved over time, with a shift from anaerobic bacteria to aerobic and nosocomial bacteria 2.
- Modern microbiology demonstrates that the lung is not sterile, and isolates in aspiration pneumonia frequently include aerobes or mixed cultures 3.
- The most common organisms causing aspiration pneumonia include:
- The microbiology of pneumonia after a macroaspiration has changed over the last 60 years, with a decrease in anaerobic infections and an increase in aerobic and nosocomial bacteria 2.
Treatment and Prevention
- Treatment for aspiration pneumonia should include antibiotic coverage for oral anaerobes, aerobes associated with community-acquired pneumonia, and resistant organisms depending on the clinical context 3.
- Antibiotic therapy has been achieved with several antibiotics, including ampicillin + sulbactam, clindamycin, and ceftriaxone 6, 5.
- Preventative measures include improved oral hygiene and positional feeding, although these have had mixed results 3.
- Understanding the complex temporal variability between microbiome-host associations is crucial for instituting microbiome-targeted strategies for preventing and treating the sequelae of aspiration pneumonia 4.